Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
09 Oct 2016 ESMO 2016: Vemurafenib Shows Clinical Benefit in Diverse BRAF V600-Mutated Tumours Personalised medicine - Anticancer agents & Biologic therapy
09 Oct 2016 ESMO 2016: Triple Combination of Dabrafenib, Trametinib, and Panitumumab Improves Efficacy in BRAF Mutation Positive mCRC Gastrointestinal cancers - Anticancer agents & Biologic therapy
09 Oct 2016 ESMO 2016: A Longer Interval Between Preoperative Chemoradiotherapy and Surgery Urged in Locally Advanced Rectal Cancer Gastrointestinal cancers
09 Oct 2016 ESMO 2016: Lenvatinib Shows Promising Activity in Patients with RET-Positive Adenocarcinoma of the Lung Lung and other thoracic tumours - Anticancer agents & Biologic therapy
09 Oct 2016 ESMO 2016: Comprehensive Genomic Profiling Identifies Potentially Actionable Mutations in Small Bowel Adenocarcinoma Translational research - Gastrointestinal cancers
09 Oct 2016 ESMO 2016 Press Release: First-line Pembrolizumab Plus Chemotherapy Significantly Improves Outcomes in Advanced NSCLC Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Greater Patient Selection May be Needed for First Line Nivolumab to Improve Progression-free Survival in Advanced Lung Cancer Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Significant Survival Gains with Atezolizumab vs Docetaxel for Non-Small-Cell Lung Cancer Head and neck cancers
09 Oct 2016 ESMO 2016 Press Release: Ceritinib Provides Longer Progression-free Survival Than Chemotherapy in Phase III Trial of ALK Rearranged Lung Cancer Treatment Lung and other thoracic tumours
09 Oct 2016 ESMO 2016 Press Release: Nintedanib Improves Progression-free Survival but not Overall Survival in Phase III Trial of Metastatic Colorectal Cancer Gastrointestinal cancers
09 Oct 2016 ESMO 2016 Press Release: Pembrolizumab New Option for First Line Treatment of Patients with Advanced Lung Cancer and High PD-L1 Expression Lung and other thoracic tumours
08 Oct 2016 ESMO 2016 Press Release: True Burden of Head and Neck Cancer in France Underestimated by More Than One-Third Head and neck cancers
08 Oct 2016 ESMO 2016: Factors Identified That Associate with Near the End of Life Chemotherapy Use Palliative and supportive care
08 Oct 2016 ESMO 2016: Antitumour Activity Demonstrated With Lurbinectedin in Patients With Metastatic Breast Cancer and BRCA Mutations Breast cancer - Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016: Trabectedin Improves PFS Over Best Supportive Care in Patients with Pretreated Advanced Soft Tissue Sarcoma Sarcomas - Anticancer agents & Biologic therapy